Linda Marsh's most recent trade in Astrana Health Inc. was a trade of 6,449 Common Stock done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astrana Health Inc. | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,449 | 83,641 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 8,982 | 27,641 (0%) | 0% | 0 | Common Stock | |
| Astrana Health Inc. | Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 11,000 | 0 | - | - | Stock Option (right to buy) | |
| Astrana Health Inc. | Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.35 per share. | 10 Sep 2024 | 11,000 | 80,714 (0%) | 0% | 15.4 | 168,850 | Common Stock |
| Astrana Health Inc. | Linda Marsh | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.93 per share. | 10 Sep 2024 | 3,522 | 77,192 (0%) | 0% | 47.9 | 168,809 | Common Stock |
| Astrana Health Inc. | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 3,564 | 69,714 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 8,000 | 18,659 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 3,650 | 66,150 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 5,059 | 10,659 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Linda Marsh | Director | Sale or transfer of securities back to the company at price $ 35.32 per share. | 14 Mar 2023 | 270,081 | 0 (0%) | 0% | 35.3 | 9,539,261 | Common Stock |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 1,600 | 5,600 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 2,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Fulgent Genetics Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Linda Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |